CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleRevenue is $1.19M, lower than 95% of all stocks globally
- PositionOperating margin is -5823%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.68BUSDvs all stocks (USD)
Revenue (TTM)
1.19MUSDvs all stocks (USD)
Profit Margin
-54.00%vs Medical Instruments & Supplies peers
Beta
1.63xvs all stocks
52-Week Change
190.06%vs all stocks
Market Capitalization
3.68BUSDvs all stocks (USD)
Enterprise Value
3.59BUSDvs all stocks (USD)
Forward P/E
-44.13xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
36.75xvs Medical Instruments & Supplies peers
Enterprise to Revenue
3.03Kxvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-43.42xvs Medical Instruments & Supplies peers
Gross Margin
37.10%vs Medical Instruments & Supplies peers
Profit Margin
-54.00%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-44.34%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-78.49%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.19MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.0170USDUpdated Sep 28, 2026Quarterly Revenue Growth
8.23%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
3.00KUSDvs all stocks (USD)
EBITDA (TTM)
-82.62MUSDvs all stocks (USD)
Net Income (TTM)
-80.06MUSDvs all stocks (USD)
Operating Cash Flow (TTM)
-61.10MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-34.29MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
350.00KUSDFY2025 · Dec 31, 2025Cost of Goods Sold
539.00KUSDFY2025 · Dec 31, 2025Gross Profit
-189.00KUSDFY2025 · Dec 31, 2025Operating Income
-76.94MUSDvs all stocks (USD)
Pre-tax Income
-72.78MUSDFY2025 · Dec 31, 2025Net Income
-72.78MUSDFY2025 · Dec 31, 2025EBIT
-76.94MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-75.87MUSDFY2025 · Dec 31, 2025Research & Development
44.72MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
32.03MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
4.21MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-72.78MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-49.76MUSDFY2025 · Dec 31, 2025Free Cash Flow
-50.08MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
80.73MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-72.78MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.07MUSDFY2025 · Dec 31, 2025Stock-based Compensation
21.46MUSDFY2025 · Dec 31, 2025Other Non-cash Items
1.15MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-274.00KUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
1.13MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-1.52MUSDFY2025 · Dec 31, 2025Capital Expenditures
-315.00KUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-20.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-315.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
0.00USDFY2025 · Dec 31, 2025Shares Outstanding
70.80MSharesUpdated Sep 28, 2026Float Shares
20.65MSharesUpdated Sep 28, 2026Shares Short
3.14MSharesUpdated Sep 28, 2026Short Ratio
5.23daysvs all stocks
Short % of Shares Outstanding
14.72%vs all stocks
% Held by Insiders
71.05%vs all stocks
% Held by Institutions
15.43%vs all stocks
Total Cash (MRQ)
101.62MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.43USDUpdated Sep 28, 2026Total Debt (MRQ)
6.77MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0681xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
9.63xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
1.41USDUpdated Sep 28, 2026Total Assets
94.54MUSDvs all stocks (USD)
Total Current Assets
83.42MUSDFY2025 · Dec 31, 2025Total Liabilities
13.88MUSDFY2025 · Dec 31, 2025Total Non-current Assets
11.12MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
5.96MUSDFY2025 · Dec 31, 2025Total Current Liabilities
7.92MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
80.73MUSDFY2025 · Dec 31, 2025Accounts Receivable
274.00KUSDFY2025 · Dec 31, 2025Inventory
136.00KUSDFY2025 · Dec 31, 2025Accounts Payable
2.78MUSDFY2025 · Dec 31, 2025Short-term Debt
1.57MUSDFY2025 · Dec 31, 2025Long-term Debt
5.96MUSDFY2025 · Dec 31, 2025Common Stock (Book)
68.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-463.28MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
80.66MUSDvs all stocks (USD)
52-Week Low
12.56USDUpdated Sep 28, 202652-Week High
58.90USDUpdated Sep 28, 202652-Week Change
190.06%vs all stocks
Beta
1.63xvs all stocks
50-Day MA
44.42USDUpdated Sep 28, 2026200-Day MA
26.63USDUpdated Sep 28, 2026Avg 10-Day Volume
608.95KSharesUpdated Sep 28, 2026Avg 30-Day Volume
603.55KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
-1.17USDUpdated Sep 28, 2026Other Income / Expense
-52.00KUSDFY2025 · Dec 31, 20254 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -5823%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: -58.23Industry median: 0.12Industry P5: -0.20Peers compared: 38.00
Profit margin is -54%, lower than 95% of its Medical Instruments & Supplies peers (median 8.3%)Significant
Profit margin: -0.54Industry median: 0.08Industry P5: -0.35Peers compared: 38.00
Return on equity is -78.5%, lower than 95% of its Medical Instruments & Supplies peers (median 5.9%)Significant
Return on equity: -0.78Industry median: 0.06Industry P5: -0.24Peers compared: 38.00
Return on assets is -44.3%, lower than 95% of its Medical Instruments & Supplies peers (median 3.6%)Significant
Return on assets: -0.44Industry median: 0.04Industry P5: -0.12Peers compared: 38.00
Current ratio is 9.63×, higher than 95% of its Medical Instruments & Supplies peers (median 2.67×)Significant
Current ratio: 9.63Industry median: 2.67Industry P95: 6.94Peers compared: 38.00
Price-to-book is 36.75×, higher than 95% of its Medical Instruments & Supplies peers (median 2.98×)Significant
Price-to-book: 36.75Industry median: 2.98Industry P95: 8.72Peers compared: 38.00
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.59
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Revenue is $1.19M, lower than 95% of all stocks globallySignificant
Revenue (USD): 1,185,000Global P5: 33,357,653.812
Market cap is $3.68B, above the global median of $1.18BNotable
Market cap (USD): 3,682,386,199Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Beijing Oriental Yuhong Waterproof Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dorman Products Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhengzhou Coal Mining Machinery Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ofilm Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Mitac Holdings Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Viva Energy Group Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Exide Industries Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Stadler Rail AG
Tier 1ProductionThroughput-Bound ConversionFlowRule
Bel Fuse Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Atmus Filtration Technologies Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Suzhou Novoprotein Scientific Co., Ltd.
3 interpretationsLiquidity Ratios ElevatedLow-Leverage Liquidity ConfigurationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Apogee Therapeutics Inc.
2 interpretationsLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Der Future Science & Technology Co., Ltd.
3 interpretationsCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration